These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23870618)

  • 21. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
    Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
    J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex.
    Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV
    Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five year follow-up of two sisters with type II sialidosis: systemic and ophthalmic findings including OCT analysis.
    Rosenberg R; Halimi E; Mention-Mulliez K; Cuisset JM; Holder M; Defoort-Dhellemmes S
    J Pediatr Ophthalmol Strabismus; 2013 Jul; 50 Online():e33-6. PubMed ID: 23819954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bergmeister's papilla in a young patient with type 1 sialidosis: case report.
    Rossi S; Gesualdo C; Tartaglione A; Bilo L; Coppola A; Simonelli F
    BMC Ophthalmol; 2020 Aug; 20(1):356. PubMed ID: 32867703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialidosis type I (cherry red spot-myoclonus syndrome).
    Ganguly S; Gabani RU; Chakraborty S; Ganguly SB
    J Indian Med Assoc; 2004 Mar; 102(3):174-5. PubMed ID: 15473282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialidosis type I: ophthalmological findings.
    Sobral I; Cachulo Mda L; Figueira J; Silva R
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25323282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sialidosis type I. Two cases in a family].
    Chinchurreta-Capote A; Beltrán-Ureña FJ; España-Contreras M
    Arch Soc Esp Oftalmol; 2005 Sep; 80(9):537-40. PubMed ID: 16193438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialidoses.
    Franceschetti S; Canafoglia L
    Epileptic Disord; 2016 Sep; 18(S2):89-93. PubMed ID: 27621198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two siblings with adult-onset sialidosis type I (cherry-red spot-myoclonus syndrome)].
    Tana T; Komine Y; Kanzato N; Kawazoe N; Fukiyama K
    Rinsho Shinkeigaku; 1995 Jul; 35(7):803-5. PubMed ID: 8777807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.
    Cao LX; Liu Y; Song ZJ; Zhang BR; Long WY; Zhao GH
    World J Clin Cases; 2021 Jan; 9(3):623-631. PubMed ID: 33553400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of severe action myoclonus in sialidoses.
    Canafoglia L; Franceschetti S; Uziel G; Ciano C; Scaioli V; Guerrini R; Visani E; Panzica F
    Epilepsy Res; 2011 Mar; 94(1-2):86-93. PubMed ID: 21330109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients.
    Caciotti A; Di Rocco M; Filocamo M; Grossi S; Traverso F; d'Azzo A; Cavicchi C; Messeri A; Guerrini R; Zammarchi E; Donati MA; Morrone A
    J Neurol; 2009 Nov; 256(11):1911-5. PubMed ID: 19568825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurophysiolgical implications in sialidosis type 1: a case report.
    Wang F; Lin L; Hu J; Zhang J; Wang K
    Int J Neurosci; 2022 Jun; 132(6):589-592. PubMed ID: 32988250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sialidosis (mucolipidosis I).
    Durand P; Gatti R; Cavalieri S; Borrone C; Tondeur M; Michalski JC; Strecker G
    Helv Paediatr Acta; 1977 Nov; 32(4-5):391-400. PubMed ID: 617984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular involvement in alpha-n-acetyl neuraminidase deficiency syndromes (sialidosis type I and II).
    Prasanna P; Sriram CS; Rodriguez SH; Kohli U
    Cardiol Young; 2021 May; 31(5):862-864. PubMed ID: 33507140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mucolipidosis type I. Sialidosis due to alpha-2-6-neuraminidase deficiency with neurological symptoms].
    Maroteaux P; Poissonnier M; Tondeur M; Strecker G; Lemonnier M
    Arch Fr Pediatr; 1978 Mar; 35(3):280-91. PubMed ID: 666524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialidosis type 2 in Japan. Clinical study in two siblings' cases and review of literature.
    Matsuo T; Egawa I; Okada S; Suetsugu M; Yamamoto K; Watanabe M
    J Neurol Sci; 1983 Jan; 58(1):45-55. PubMed ID: 6405017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infantile type 2 sialidosis in a Pakistani family--a clinical and biochemical study.
    King M; Cockburn F; MacPhee GB; Logan RW
    J Inherit Metab Dis; 1984; 7(3):91-6. PubMed ID: 6438403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of middle-aged onset sialidosis type I].
    Sakazume Y; Tanaka M; Isobe I; Tominaga R; Nanba E; Okamoto K
    Rinsho Shinkeigaku; 2004 Aug; 44(8):541-4. PubMed ID: 15471091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Pathogenic Variant in the
    Sahoo LK; Kota V; Panigrahi PK; Pattnaik S; Mishra AP; Sahoo SK;
    Neurology; 2023 Nov; 101(19):861-862. PubMed ID: 37604664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.